二、簡答題
1. The primary challenge in oncological pharmacology is achieving site-specific delivery while minimizing systemic toxicity. You are tasked with designing a drug delivery vehicle for a novel lung cancer therapeutic that must bypass the systemic circulation and selectively enter the cytoplasm of malignant lung epithelial cells. Discuss the molecular mechanisms you would exploit to ensure this specificity. In your response, compare the efficacy of targeting the extracellular matrix (ECM) with that of receptor-mediated endocytosis. Why is the mere chemical property of the drug (such as hydrophobicity) insufficient for achieving high tissue specificity in a complex multicellular organism?